$10.0M
sold in all offerings
RenovoRx, Inc. is a corporation based in Mountain View, CA in the Biotechnology industry group. From April 9, 2026 to April 9, 2026 it filed 1 private fundraising filing for 1 offering and reported $10 million sold in all. It is a listed company (RNXT).
Updated October 10, 2026 · newest filing Apr 9, 2026
Amount sold
$10.0M
All offerings, newest filing of each
Offered
$10.0M
Total amount sought
Offerings
1
1 filing with amendments
Newest offering
$10.0M
Sold, first filed Apr 9, 2026
Investors
16
In the newest offering
Min. investment
$10K
In the newest offering
Facts
- Type
- Corporation
- Place
- Mountain View, CA
- Industry group
- Biotechnology
- Listed
- RNXT
- First filing
- April 9, 2026
- Newest filing
- April 9, 2026
- Exemptions
- 506(b)
Offerings
1 offering, newest first, each at its newest filing
| First filed | Amount sold | Offered | Investors | Min. investment | Exemptions | Securities |
|---|---|---|---|---|---|---|
| Apr 9, 2026 | $10.0M | $10.0M | 16 | $10K | 506(b) | Equity, Options or warrants, Securities on exercise of options |
Filing history
1 filing, newest first. An amendment updates an earlier offering.
| Filed | Kind | Amount sold | Offered | Investors |
|---|---|---|---|---|
| Apr 9, 2026 | New offering | $10.0M | $10.0M | 16 |
Related pages
Questions and answers
How much has RenovoRx, Inc. raised in private offerings?
$10 million sold in 1 private offering reported from Apr 9, 2026 to Apr 9, 2026, counting each offering once at its newest filing.
When did RenovoRx, Inc. last file about a private offering?
April 9, 2026. Its newest offering reported $10 million sold of $10 million offered to 16 investors.
Which exemption does RenovoRx, Inc. use?
506(b). Rule 506(b) does not allow public advertising.
Is RenovoRx, Inc. a listed company?
Yes, it is listed as RNXT.
These are notices that issuers file about their own private offerings, not verified results. Amounts are as stated in the filing. Official public data from private fundraising filings, updated daily. Amount sold is what the issuer had sold when it filed; the offered amount is the total it wants to raise.